550 related articles for article (PubMed ID: 23614931)
1. Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
Manolova I; Gerenova J; Ivanova M
Eur Cytokine Netw; 2013 Mar; 24(1):69-74. PubMed ID: 23614931
[TBL] [Abstract][Full Text] [Related]
2. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels.
Akinci B; Comlekci A; Yener S; Bayraktar F; Demir T; Ozcan MA; Yuksel F; Yesil S
Arch Med Res; 2008 May; 39(4):397-401. PubMed ID: 18375250
[TBL] [Abstract][Full Text] [Related]
3. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis.
Vural P; Degirmencioglu S; Erden S; Gelincik A
Int Immunopharmacol; 2009 Feb; 9(2):212-5. PubMed ID: 19028605
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus.
Jin T; Almehed K; Carlsten H; Forsblad-d'Elia H
Lupus; 2012 Mar; 21(3):310-8. PubMed ID: 22072025
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
6. The Role of Transforming Growth Factor-β1 Gene Polymorphism and Its Serum Levels in Hashimoto's Thyroiditis.
Stanilova SA; Gerenova JB; Miteva LD; Manolova IM
Curr Pharm Biotechnol; 2018; 19(7):581-589. PubMed ID: 30070177
[TBL] [Abstract][Full Text] [Related]
7. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
Sayed SK; Galal SH; Herdan OM; Mahran AM
Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of the regulatory cytokines transforming growth factor-β and interleukin-10 are reduced in patients with discoid lupus erythematosus.
Antiga E; Del Bianco E; Difonzo E; Fabbri P; Caproni M
Lupus; 2011 May; 20(6):556-60. PubMed ID: 21372199
[TBL] [Abstract][Full Text] [Related]
10. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
[TBL] [Abstract][Full Text] [Related]
11. Single-nucleotide polymorphisms of transforming growth factor-beta1 gene in Taiwanese patients with systemic lupus erythematosus.
Lu LY; Cheng HH; Sung PK; Yeh JJ; Shiue YL; Chen A
J Microbiol Immunol Infect; 2004 Jun; 37(3):145-52. PubMed ID: 15221033
[TBL] [Abstract][Full Text] [Related]
12. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
Xing Q; Su H; Cui J; Wang B
Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of human amniotic epithelial cells in murine models of Hashimoto's thyroiditis and Systemic lupus erythematosus.
Tan B; Yuan W; Li J; Yang P; Ge Z; Liu J; Qiu C; Zhu X; Qiu C; Lai D; Guo L; Wang L; Yu L
Cytotherapy; 2018 Oct; 20(10):1247-1258. PubMed ID: 30174233
[TBL] [Abstract][Full Text] [Related]
14. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients.
Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G
Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994
[TBL] [Abstract][Full Text] [Related]
16. Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
Cabral de Sousa D; das Chagas Medeiros MM; Trindade Viana VS; Salani Mota RM
Lupus; 2005; 14(8):618-24. PubMed ID: 16175934
[TBL] [Abstract][Full Text] [Related]
17. Hashimoto's thyroiditis with elevated serum IgG4 concentrations is not equivalent to IgG4 Hashimoto's thyroiditis.
Yu Y; Yu N; Lu G; Li T; Zhang Y; Zhang J; Gao Y; Gao Y; Guo X
Clin Endocrinol (Oxf); 2018 Jun; 88(6):943-949. PubMed ID: 29520804
[TBL] [Abstract][Full Text] [Related]
18. Arg25Pro (c.915G>C) polymorphism of transforming growth factor β1 gene suggests an association with increased risk for Hashimoto's thyroiditis.
Vural P; Değirmencioğlu S; Doğru-Abbasoğlu S; Baki M; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2015 Sep; 28(1):521-4. PubMed ID: 26218277
[TBL] [Abstract][Full Text] [Related]
19. Hashimoto thyroiditis, anti-thyroid antibodies and systemic lupus erythematosus.
Posselt RT; Coelho VN; Skare TL
Int J Rheum Dis; 2018 Jan; 21(1):186-193. PubMed ID: 28544477
[TBL] [Abstract][Full Text] [Related]
20. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus.
Yuan Y; Yang M; Wang K; Sun J; Song L; Diao X; Jiang Z; Cheng G; Wang X
Arthritis Res Ther; 2017 Mar; 19(1):70. PubMed ID: 28356164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
